MartinWilliamSchoenMDMPH
Oncology • Saint Louis, MOHematologic Oncology
Assistant Professor of Medicine, Saint Louis University
Dr. Schoen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
915 North Grand Blvd.
4th Floor
Saint Louis, MO 63106Phone+1 314-289-6305- Is this information wrong?
Summary
- Dr. Martin Schoen is a hematologist/oncologist at the St. Louis Veterans Affairs Medical Center and Saint Louis University specializes in the treatment of prostate cancer, hematologic malignancies, and breast cancer. His research focuses on outcomes, disparities, and adverse events using nationwide data available from the VA to personalize treatment of cancer.
Education & Training
St Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019- St Louis University School of MedicineResidency, Internal Medicine, 2013 - 2016
University of North Carolina at Chapel HillMPH, Health Policy and Management, 2008 - 2010
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MO State Medical License 2013 - 2025
NC State Medical License 2012 - 2025
AL State Medical License Active through 2008- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Banana for Best Resident Teacher Saint Louis University Class of 2016, 2016
- Caring Physician Award SSM Saint Louis University Hospital, 2015
Clinical Trials
- Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) Start of enrollment: 2020 May 20
- Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization Start of enrollment: 2020 Jul 06
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC Start of enrollment: 2021 Jun 09
- Join now to see all
Publications & Presentations
PubMed
- Survival in Patients With De Novo Metastatic Prostate Cancer.R Bruce Montgomery, Lukas Owens, Saira Khan, Kristen M Sanfilippo, Ruth B Etzioni, Schoen, M. W., Martin W Schoen> ;JAMA Network Open. 2024 Mar 4
- Lobe-specific lymph node sampling is associated with lower risk of cancer recurrence.Schoen, M. W., Melanie P Subramanian, Daniel B Eaton Jr, Brendan T Heiden, Whitney S Brandt, Ulysses L Labilles, Su-Hsin Chang, Yan Yan, Martin W Schoen, Mayank R Pate...> ;JTCVS Open. 2024 Feb 1
- Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.Srinivas Govindan, Suhong Luo, Nina Cheranda, Forest Riekhof, Schoen, M. W., Martin W Schoen> ;The Prostate. 2024 Feb 1
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and BendamustineSchoen MW, Sanfilippo KM, Luo S, Mohammed KA, Carson KR, ASH 2017, Atlanta, GA, 12/2017
- Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia RiskSchoen MW, Woelich SK, Braun JT et. al, ASH 2016, San Diego, CA, 12/2016
- Outcomes of Acute Myeloid Leukemia Induction with Addition of CladribineSchoen MW, Braun J, Woelich S, Ramlal R, Schmidt A, Freter CE, Lionberger JM, Missouri ACP, First Place Award: Research Poster, 9/1/2015
- Join now to see all
Lectures
- Outcomes of Black Patients with Multiple Myeloma in the Veterans Health AdministrationAmerican Society of Hematology Annual Meeting - 12/3/2018
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Survival Edge Found Among Black US Veterans with mCRPCFebruary 17th, 2023- Enzalutamide, Abiraterone Compared for mCRPC with ComorbiditiesDecember 1st, 2022
Myeloma Outcomes of Black Veterans Differ from Non-VeteransDecember 8th, 2018- Join now to see all
Research History
- Outcomes Researcher, Veterans AffairsI have conducted outcomes research in the Veterans Affairs to understand differences in treatment based on comorbidities and race.2016 - Present
- Project Manager/ResearcherCenter for Public Health Systems Science at Washington University in St. Louis2012 - 2013
- Student InvestigatorDivision of Sleep Medicine, Harvard Medical School2003 - 2006
Professional Memberships
- Associate
- Member
Other Languages
- Spanish
Hospital Affiliations
John J. Cochran Veterans HospitalSaint Louis, Missouri
SSM Health Saint Louis University HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
